2nd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases

LobbyistCovered position, as disclosed
LAURA JOHNSON BOLLIER —
NADEAM ELSHAMI —
EMILY FELDER New Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
MARC LAMPKIN —
BRIAN MCKEON —
JEROME MURRAY —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); SENATE

Environment/Superfund ENV

Issues related to corporate environmental sustainability

LobbyistCovered position, as disclosed
LAURA JOHNSON BOLLIER —
NADEAM ELSHAMI —
BRIAN MCKEON —
JEROME MURRAY —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: Internal Revenue Service (IRS); SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax filing programs

LobbyistCovered position, as disclosed
ROSEMARY BECCHI New Tax Counsel, Senate Finance Committee

Contacted: HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.